Suicide In Bipolar Disorder Treatment Patients As The Foremost Cause Of Death, Reveal Researchers



Suicide In Bipolar Disorder Treatment Patient Is Very Common

Despite the contention that psychiatric treatment effectively reduces suicide rates in individuals with bipolar disorder (BD), recent research reveals that suicide in bipolar disorder treatment patients remains the primary cause of death among this group, even after receiving treatment.

Furthermore, contrary to the belief that those who die by suicide are often not taking their prescribed medications, the researchers say that 48% of suicide cases in this population are the result of overdosing on psychiatric drugs.

Why Suicide In Bipolar Disorder Treatment Patients Is The Primary Cause Of Death?

The study encompassed 47,018 individuals diagnosed with bipolar disorder, meticulously identified through a comprehensive Finnish nationwide registry that cataloged those who underwent extensive treatment for BD, comprising both inpatient hospitalizations and outpatient care.

The study cohort consisted of participants diagnosed with bipolar disorder between 1998 and 2018, falling within the age range of 15 to 65 years from 2004 to 2018. The median duration of follow-up was approximately eight years.

Over the course of the research, a total of 3,300 individuals (7% of the cohort) experienced mortality.

Among the various causes of death, suicide stood as the most prevalent, accounting for 740 fatalities, with 48% (353 individuals) of these suicides being attributed to overdosing on psychiatric drugs.

Additionally, the data identified 265 deaths categorized as “accidental poisonings,” of which 46% (123 deaths) were attributed to overdosing on psychiatric drugs.

Notably, there remains ambiguity regarding whether a subset of the deaths designated as “accidental poisonings” could potentially be reclassified as “suicides,” considering the tendency for societal stigma to lead to suicide cases being recorded as unintentional suicide in Bipolar Disorder treatment incidents in official records.

Read more here: Alarming Surge: Alcohol Related Deaths Among Women On The Rise, New Study Finds

The second most frequent cause of death was linked to alcohol-related factors, encompassing 595 fatalities. This category included instances of alcohol-related liver disease, alcohol poisoning, and alcohol dependence.

Furthermore, cardiovascular disease (CVD) accounted for an additional 552 deaths.

Research findings indicated that individuals under antipsychotic treatment faced a more than threefold heightened risk of succumbing to CVD, even after meticulous adjustment for confounding variables.

Notably, those utilizing a combined bipolar disorder treatments regimen of phenothiazine-type antipsychotics and antidepressants exhibited a staggering 18-fold increase in the risk of CVD-related mortality compared to the general population.

Common Causes Of Death In Bipolar Disorder Treatment

Suicide: Despite treatment, suicide remains a significant risk for individuals with bipolar disorder.

Accidental Overdose: Overdosing on psychiatric medications can occur, leading to fatal outcomes.

Cardiovascular Disease: Some medications used in bipolar disorder treatment may increase the risk of cardiovascular issues.

Substance Abuse: Co-occurring substance abuse disorders can lead to health complications and overdose.

Read more here: 3 Powerful Pointers That Will Help In Preventing Substance Abuse

Other Health Conditions: Individuals with bipolar disorder may be at an increased risk of other physical health problems, such as diabetes and obesity, which can contribute to premature death.

New Study says suicide in bipolar disorder treatment patients is the leading cause of death.

It’s important to emphasize that effective treatment, support, and monitoring can significantly reduce the risk of common causes of death in bipolar disorder treatment.

On multiple occasions, researchers have observed that individuals diagnosed with severe mental illnesses commonly experience a lifespan that is notably shorter by several decades compared to the general population.

Despite notable advancements in treatment accessibility, a recent investigation conducted in the United Kingdom highlights that this divergence in mortality rates, referred to as the “mortality gap,” continues to expand.

The present researchers propose a reorientation of focus within psychiatry towards the prevention of substance abuse and suicidal tendencies.

However, it’s important to note that they refrain from elaborating on the particular distinctions between these new priorities and the existing bipolar disorder treatments objective.

bipolar disorder treatments

— Share —

— About the Author —

Leave a Reply

Up Next

Study Reveals Significant Genetic Link Between Treatment-Resistant Depression and Family History

In a groundbreaking study published in the journal JAMA Psychiatry, researchers have uncovered a substantial genetic link between treatment-resistant depression (TRD) and family history.

Led by Dr. Cheng-Ta Li, a professor of medicine at the National Yang-Ming Chiao Tung University in Taipei, Taiwan, the study utilized extensive national health insurance data to investigate the transmission of TRD across generations and its association with other psychiatric disorders.

The findings of the study are particularly significant, as they shed light on the hereditary nature of TRD and its implications for early intervention and treatment.

Up Next

FDA Clears Prescription Digital Therapeutic for Adults with Major Depressive Disorder

The FDA has recently cleared a groundbreaking prescription digital therapeutic, known as Rejoyn, for the treatment of major depressive disorder (MDD) symptoms in adults. This innovative therapy, developed by Otsuka Pharmaceutical Co. Ltd. in collaboration with Click Therapeutics Inc., aims to provide adjunctive care for individuals who have been prescribed antidepressants as part of clinician-managed outpatient treatment.

Rejoyn is a 6-week treatment program designed to assist individuals aged 22 years and older in regulating their emotions through a combination of clinically validated cognitive training exercises and therapeutic lessons.

The therapy utilizes digital platforms to deliver pe

Up Next

Sweet Science: How Chocolate’s Theobromine May Aid Weight Loss and Alzheimer’s Prevention

A recent study conducted by researchers at Zhengzhou University in China suggests that indulging in chocolate could offer various health benefits, including weight loss assistance and Alzheimer’s prevention.

Published in the Journal of Functional Foods, the study highlights the potential of a chemical compound found in chocolate called theobromine to positively impact both the body and the brain.

Theobromine, present in cocoa beans, boasts anti-inflammatory properties and is rich in antioxidants, making it beneficial for brain health. According to scientists, this compound can protect against Alzhei

Up Next

New Study Finds High Genetic Risk for Obesity May Require Over 14,500 Daily Steps

A recent study published in JAMA Network Open reveals a significant association between genetic risk for obesity and the amount of physical activity required to mitigate the risk.

Led by Dr. Evan Brittain, associate professor of medicine at Vanderbilt University Medical Center, the study analyzed data from 3,124 participants in the National Institutes of Health’s All of Us Research Program to explore the link between genetic predisposition to obesity and recommended step counts for reducing the genetic risk of developing the condition.

Findings from the study indicate that individuals with a higher genetic risk of obesity may need to undertake more physical activity

Up Next

Ketogenic Diets Show Promise for Bipolar Disorder and Schizophrenia Treatment, Stanford Study Finds

A recent study led by researchers at Stanford University suggests that ketogenic diets may offer benefits for individuals with bipolar disorder and schizophrenia, shedding light on the potential role of diet in managing serious mental illnesses.

The findings, published in Psychiatry Research, highlight the positive impact of a ketogenic regime on both psychiatric outcomes and metabolic syndromes commonly associated with these conditions.

Unlike traditional diets, ketogenic diets are characterized by high fat, moderate protein, and very low carbohydrate intake. The study, led by Dr. Shebani Sethi, a clinical ass

Up Next

Trend Alert: “Patientsplaining” on the Rise as Americans Share Online Health Research with Doctors

A recent survey conducted by market research company OnePoll for Vimergy sheds light on a growing trend among Americans dubbed as “patientsplaining,” where individuals discuss their online health findings with their doctors. The survey, which included 2,000 general population Americans, explored how people invest time in their health and interact with healthcare professionals.

According to the findings, seven in 10 Americans (68%) admit to engaging in “patiensplaining,” wherein they share their online health research with their doctors. This behavior reflects a broader trend of increased interest and involvement in personal health matters, with three in four respondents (77%) reporting that they conduct health-related research in their spare time.

Prevalence of Patientsplaining

Up Next

New Study Raises Concerns About Impact of Metformin on Offspring’s Brain Development During Pregnancy

In a groundbreaking study shedding light on the complexities of managing gestational diabetes risks, researchers from the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE) have uncovered potential concerns regarding the impact of metformin on offspring’s brain development during pregnancy.

Published in the prestigious journal Molecular Metabolism, this research underscores the urgent need for preventive strategies and careful consideration of treatment options for pregnant individuals with diabetes.

Rising Cases of Gestational Diabetes

With the prevalence of gestational diabetes and metabolic disorders on the rise during pregnancy, the prescription of metformin has become increasingly common. However, the effects of this oral antidiabetic medication on the developing brain of